Anhui Wanbang Pharmaceutical Co. Ltd. (301520)

Overview

Anhui Wanbang Pharmaceutical Technology Co., Ltd., established in 2006 and headquartered in Hefei, China, is a pivotal entity that specializes in providing comprehensive support for the pharmaceutical industry. The company focuses on the crucial stages of drug development, including research, development, and the facilitation of clinical trials. With its expertise, Anhui Wanbang Pharmaceutical Technology plays a vital role in assisting drug manufacturers and marketing authorization holders within the Chinese market, ensuring that innovative therapeutic solutions can navigate the complex path from concept to commercialization efficiently and effectively.

Products and Services

• Drug Research and Development

At the core of Anhui Wanbang Pharmaceutical Technology's offerings is its drug research and development service. This encompasses a wide range of activities from the initial discovery of active pharmaceutical ingredients, through to preclinical research, formulation development, and process optimization. This service is designed to streamline the development of new drugs, making it faster and more cost-efficient for clients to bring new treatments to the market.

• Clinical Trial Services

The company also specializes in managing and executing clinical trials. With a focus on both regulatory compliance and scientific rigor, Anhui Wanbang Pharmaceutical Technology supports its clients through each phase of clinical research, from Phase I trials that assess safety and dosage through to Phase III trials that evaluate the effectiveness of a new treatment compared to current standards. These services ensure that clients can accurately assess the efficacy, safety, and potential market success of their products.